A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Biochem Pharmacol
; 95(1): 16-27, 2015 May 01.
Article
in En
| MEDLINE
| ID: mdl-25795251
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Drug Resistance, Neoplasm
/
MAP Kinase Signaling System
/
Proto-Oncogene Proteins B-raf
/
Indoles
/
Melanoma
/
Antineoplastic Agents
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Biochem Pharmacol
Year:
2015
Document type:
Article
Affiliation country:
Italia
Country of publication:
Reino Unido